David Rimm
David Rimm
Verified email at yale.edu - Homepage
Cited by
Cited by
X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization
RL Camp, M Dolled-Filhart, DL Rimm
Clinical cancer research 10 (21), 7252-7259, 2004
Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma
LA Garraway, HR Widlund, MA Rubin, G Getz, AJ Berger, S Ramaswamy, ...
Nature 436 (7047), 117-122, 2005
The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014
R Salgado, C Denkert, S Demaria, N Sirtaine, F Klauschen, G Pruneri, ...
Annals of oncology 26 (2), 259-271, 2015
Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features
CJ Creighton, X Li, M Landis, JM Dixon, VM Neumeister, A Sjolund, ...
Proceedings of the National Academy of Sciences 106 (33), 13820-13825, 2009
Adhesion between epithelial cells and T lymphocytes mediated by E-cadherin and the α E β 7 integrin
KL Cepek, SK Shaw, CM Parker, GJ Russell, JS Morrow, DL Rimm, ...
Nature 372 (6502), 190-193, 1994
Validation of tissue microarray technology in breast carcinoma
RL Camp, LA Charette, DL Rimm
Laboratory investigation 80 (12), 1943-1949, 2000
Alpha 1 (E)-catenin is an actin-binding and-bundling protein mediating the attachment of F-actin to the membrane adhesion complex
DL Rimm, ER Koslov, P Kebriaei, CD Cianci, JS Morrow
Proceedings of the National Academy of Sciences 92 (19), 8813-8817, 1995
Molecular classification identifies a subset of human papillomavirus–associated oropharyngeal cancers with favorable prognosis
PM Weinberger, Z Yu, BG Haffty, D Kowalski, M Harigopal, J Brandsma, ...
Journal of clinical oncology 24 (5), 736-747, 2006
Automated subcellular localization and quantification of protein expression in tissue microarrays
RL Camp, GG Chung, DL Rimm
Nature medicine 8 (11), 1323-1328, 2002
Programmed death ligand-1 expression in non-small cell lung cancer
V Velcheti, KA Schalper, DE Carvajal, VK Anagnostou, KN Syrigos, ...
Laboratory investigation 94 (1), 107-116, 2014
Antibody validation
J Bordeaux, AW Welsh, S Agarwal, E Killiam, MT Baquero, JA Hanna, ...
Biotechniques 48 (3), 197-209, 2010
Expression profiling reveals novel pathways in the transformation of melanocytes to melanomas
K Hoek, DL Rimm, KR Williams, H Zhao, S Ariyan, A Lin, HM Kluger, ...
Cancer research 64 (15), 5270-5282, 2004
Quantitative assessment of the heterogeneity of PD-L1 expression in non–small-cell lung cancer
J McLaughlin, G Han, KA Schalper, D Carvajal-Hausdorf, V Pelekanou, ...
JAMA oncology 2 (1), 46-54, 2016
Differences in risk factors for breast cancer molecular subtypes in a population-based study
XR Yang, ME Sherman, DL Rimm, J Lissowska, LA Brinton, B Peplonska, ...
Cancer Epidemiology and Prevention Biomarkers 16 (3), 439-443, 2007
A prospective, multi-institutional, pathologist-based assessment of 4 immunohistochemistry assays for PD-L1 expression in non–small cell lung cancer
DL Rimm, G Han, JM Taube, SY Eunhee, JA Bridge, DB Flieder, R Homer, ...
JAMA oncology 3 (8), 1051-1058, 2017
Frequent mutation and nuclear localization of β-catenin in anaplastic thyroid carcinoma
G Garcia-Rostan, G Tallini, A Herrero, GD Thomas, ML Carcangiu, ...
Cancer research 59 (8), 1811-1815, 1999
In situ tumor PD-L1 mRNA expression is associated with increased TILs and better outcome in breast carcinomas
KA Schalper, V Velcheti, D Carvajal, H Wimberly, J Brown, L Pusztai, ...
Clinical Cancer Research 20 (10), 2773-2782, 2014
Receptor protein tyrosine phosphatase PTPmu associates with cadherins and catenins in vivo.
SM Brady-Kalnay, DL Rimm, NK Tonks
The Journal of cell biology 130 (4), 977-986, 1995
Activated Wnt/-catenin signaling in melanoma is associated with decreased proliferation in patient tumors and a murine melanoma model
AJ Chien, EC Moore, AS Lonsdorf, RM Kulikauskas, BG Rothberg, ...
Proceedings of the National Academy of Sciences 106 (4), 1193-1198, 2009
Tissue microarray: a new technology for amplification of tissue resources.
DL Rimm, RL Camp, LA Charette, J Costa, DA Olsen, M Reiss
Cancer journal (Sudbury, Mass.) 7 (1), 24-31, 2001
The system can't perform the operation now. Try again later.
Articles 1–20